Red Tortoise LLC’s Nuvation Bio NUVB Stock Holding History

Red Tortoise LLC’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-769	Closed	-$1.28K	–	603
2023 Q1	$1.28K	Buy	+769	New	+$1.56K	﹤0.01%	520

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Red Tortoise LLC's NUVB Position: Q2 2023 in Review

Red Tortoise LLC sold out of Nuvation Bio (NUVB) in Q2 2023, closing a stake of 769 shares — an estimated $1.28K sold.

Red Tortoise LLC first reported a position in NUVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.28K in Q1 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q2 2023.

Red Tortoise LLC reported no remaining Nuvation Bio position as of Q2 2023 after selling out during the quarter.
Red Tortoise LLC sold 769 Nuvation Bio shares in Q2 2023, an estimated $1.28K.
Red Tortoise LLC first reported a position in Nuvation Bio in Q1 2023 and held it in 1 quarter.
Red Tortoise LLC's Nuvation Bio position peaked at $1.28K in Q1 2023.
124 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2023.

Based on Red Tortoise LLC's 13F filing for Q2 2023, filed 26 Jul 2023.